Design and synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold. 1998

J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
Solvay Pharmaceuticals Research Laboratory, Weesp, The Netherlands. jan.vanmaarseveen@solvay.com

The design and synthesis of an orally active LMW non-peptide GPIIb/IIIa antagonist, based on a N,N'-bisphenylpiperazine scaffold, is described. The optimal compound showed a high in vitro binding potency (pIC50 = 8.7) in combination with potent oral antithrombotic activity (30-40% inhibition of thrombus growth at 0.3-3 mg/kg) with a duration of action of > 90 min. in a hamster cheek pouch model.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
May 2001, Medicinal research reviews,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
September 1994, Bioorganic & medicinal chemistry,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
March 2000, Thrombosis research,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
April 1997, The Journal of organic chemistry,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
April 2001, Journal of medicinal chemistry,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
February 2001, Thrombosis research,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
December 1996, Journal of medicinal chemistry,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
February 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
March 2001, Chemical & pharmaceutical bulletin,
J H van Maarseveen, and J A den Hartog, and K Tipker, and J H Reinders, and J Brakkee, and U Schön, and W Kehrbach, and C G Kruse
January 2001, Cardiovascular drug reviews,
Copied contents to your clipboard!